ARTICLE | Clinical News
Sirolimus regulatory update
November 21, 2011 8:00 AM UTC
Santen's Santen Inc. subsidiary said FDA granted Orphan Drug designation for Santen's sirolimus to treat several opthalmic indications. The indications are: chronic/refractory anterior non-infectious...